Healthcare & Medical Devices Global On demand · 24-48h

Global Aortic and Peripheral Vascular Intervention Device Market Strategic Research Report

Global Aortic and Peripheral Vascular Intervention Device Ma…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Aortic and Peripheral Vascular Intervention Device Market
$2.79B2025
16.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Drug Stent, Balloon Catheter, Other

By Application: Lower Extremity Artery, Renal Artery, Carotid Artery

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Medtronic, Gore, BD, Boston Scientific, Abbott Laboratories, Cordis, Biotronik, Terumo Corporation, MicroPort Endovascular MedTech, Cookmedical, Lepu Medical, Zylox-Tonbridge, Lifetech

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 108 pages
Market size 2025
$2.79B
Billion USD
Forecast CAGR
16.4%
2025-2032
Forecast 2032
$8.1B
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Aortic and Peripheral Vascular Intervention Device market size is predicted to grow from US$ 2,790 million in 2025 to US$ 7,922 million in 2032; it is expected to grow at a CAGR of 16.4% from 2026 to 2032.

Aortic and peripheral vascular intervention devices are medical devices used to treat various conditions related to the aorta and the peripheral vascular system. These devices can be used to treat conditions such as aneurysms, stenosis, and other vascular abnormalities. Aortic intervention devices include stent grafts, which are used to repair aneurysms in the aorta. Stent grafts are typically made of a fabric tube supported by a metal frame, which is inserted into the damaged area of the aorta to reinforce the weakened walls and prevent rupture. Endovascular stent grafts are also used to treat aortic dissections and other conditions affecting the aorta. Peripheral vascular intervention devices include stents, which are small metal tubes that are used to prop open narrowed or blocked blood vessels. These devices are typically inserted through a small incision in the skin and guided to the affected area using imaging technology such as X-rays or ultrasound. Balloon angioplasty devices may also be used to widen narrowed or blocked vessels, by inflating a small balloon in the vessel to open up the narrowed area.

Global key Aortic and Peripheral Vascular Intervention Device players cover Medtronic, Gore, BD, Boston Scientific, Abbott Laboratories, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Aortic and Peripheral Vascular Intervention Device market?

What factors are driving Aortic and Peripheral Vascular Intervention Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Aortic and Peripheral Vascular Intervention Device market opportunities vary by end market size?

How does Aortic and Peripheral Vascular Intervention Device break out by Type, by Application?

This report presents a comprehensive overview of the global Aortic and Peripheral Vascular Intervention Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Drug Stent
  • Balloon Catheter
  • Other

Segment by Application

  • Lower Extremity Artery
  • Renal Artery
  • Carotid Artery

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Aortic and Peripheral Vascular Intervention Device market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Lower Extremity Artery, Renal Artery, Carotid Artery evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Aortic and Peripheral Vascular Intervention Device Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 16.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.79B
2025
Forecast
$8.1B
2032
CAGR
16.4%
2025–2032
Regiões
5
global
Key companies
MedtronicGoreBDBoston ScientificAbbott LaboratoriesCordisBiotronikTerumo Corporation
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Drug StentBalloon CatheterOther
By Application
Lower Extremity ArteryRenal ArteryCarotid Artery

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Drug Stent
  • 3.1.3 Balloon Catheter
  • 3.1.4 Other
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Lower Extremity Artery
  • 4.1.3 Renal Artery
  • 4.1.4 Carotid Artery
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Medtronic
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Gore
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 BD
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Boston Scientific
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Abbott Laboratories
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Cordis
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Biotronik
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Terumo Corporation
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 MicroPort Endovascular MedTech
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Cookmedical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Lepu Medical
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Zylox-Tonbridge
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Lifetech
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Aortic and Peripheral Vascular Intervention Device market?
The global Aortic and Peripheral Vascular Intervention Device market is estimated at US$ 2.79 billion in 2025 (base year) and is projected to reach US$ 7.92 billion by 2032.
What is the forecast CAGR for the Aortic and Peripheral Vascular Intervention Device market?
The market is expected to grow at a CAGR of 16.4% from 2026 to 2032, expanding from US$ 2.79 billion in 2025 to US$ 7.92 billion in 2032, roughly 2.8 times its base-year value.
What is Aortic and Peripheral Vascular Intervention Device?
Aortic and peripheral vascular intervention devices are medical devices used to treat various conditions related to the aorta and the peripheral vascular system. These devices can be used to treat conditions such as aneurysms, stenosis, and other vascular abnormalities. Aortic intervention devices include stent grafts, which are used to repair aneurysms in the aorta.
How is the Aortic and Peripheral Vascular Intervention Device market segmented by type?
By type, the market is segmented into Drug Stent, Balloon Catheter and Other.
What are the key applications of Aortic and Peripheral Vascular Intervention Device?
Key applications covered include Lower Extremity Artery, Renal Artery and Carotid Artery.
Which companies are profiled in the Aortic and Peripheral Vascular Intervention Device market report?
Key players profiled include Medtronic, Gore, BD, Boston Scientific, Abbott Laboratories, Cordis, Biotronik and Terumo Corporation, among 13 companies covered in total.
What geographies does the Aortic and Peripheral Vascular Intervention Device market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Aortic and Peripheral Vascular Intervention Device?
What factors are driving Aortic and Peripheral Vascular Intervention Device market growth, globally and by region?
Who should buy the Aortic and Peripheral Vascular Intervention Device market report?
The report is intended for manufacturers and solution providers, distributors and end users in Lower Extremity Artery, Renal Artery and Carotid Artery, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Aortic and Peripheral Vascular Intervention Device market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.